| UniProt ID | RL35A_HUMAN | |
|---|---|---|
| UniProt AC | P18077 | |
| Protein Name | 60S ribosomal protein L35a | |
| Gene Name | RPL35A | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 110 | |
| Subcellular Localization | ||
| Protein Description | Required for the proliferation and viability of hematopoietic cells. Plays a role in 60S ribosomal subunit formation. The protein was found to bind to both initiator and elongator tRNAs and consequently was assigned to the P site or P and A site.. | |
| Protein Sequence | MSGRLWSKAIFAGYKRGLRNQREHTALLKIEGVYARDETEFYLGKRCAYVYKAKNNTVTPGGKPNKTRVIWGKVTRAHGNSGMVRAKFRSNLPAKAIGHRIRVMLYPSRI | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MSGRLWSKA ------CCCCHHHHH | 32.40 | 29514088 | |
| 4 | Methylation | ----MSGRLWSKAIF ----CCCCHHHHHHH | 26.19 | 115492145 | |
| 8 | Acetylation | MSGRLWSKAIFAGYK CCCCHHHHHHHHHHH | 33.64 | 19608861 | |
| 8 | 2-Hydroxyisobutyrylation | MSGRLWSKAIFAGYK CCCCHHHHHHHHHHH | 33.64 | - | |
| 8 | Ubiquitination | MSGRLWSKAIFAGYK CCCCHHHHHHHHHHH | 33.64 | 23000965 | |
| 14 | Phosphorylation | SKAIFAGYKRGLRNQ HHHHHHHHHHHHCCC | 8.29 | 24719451 | |
| 15 | 2-Hydroxyisobutyrylation | KAIFAGYKRGLRNQR HHHHHHHHHHHCCCC | 38.79 | - | |
| 15 | Acetylation | KAIFAGYKRGLRNQR HHHHHHHHHHHCCCC | 38.79 | 25953088 | |
| 15 | Ubiquitination | KAIFAGYKRGLRNQR HHHHHHHHHHHCCCC | 38.79 | 27667366 | |
| 25 | Phosphorylation | LRNQREHTALLKIEG HCCCCCCEEEEEEEE | 17.78 | 28152594 | |
| 29 | Ubiquitination | REHTALLKIEGVYAR CCCEEEEEEEEEECC | 39.29 | 21963094 | |
| 29 | Acetylation | REHTALLKIEGVYAR CCCEEEEEEEEEECC | 39.29 | 25825284 | |
| 34 | Phosphorylation | LLKIEGVYARDETEF EEEEEEEECCCCCEE | 13.53 | 28102081 | |
| 39 | Phosphorylation | GVYARDETEFYLGKR EEECCCCCEEEECCE | 35.37 | 28152594 | |
| 42 | Phosphorylation | ARDETEFYLGKRCAY CCCCCEEEECCEEEE | 14.33 | 28152594 | |
| 45 | Ubiquitination | ETEFYLGKRCAYVYK CCEEEECCEEEEEEE | 41.53 | 23000965 | |
| 45 | Succinylation | ETEFYLGKRCAYVYK CCEEEECCEEEEEEE | 41.53 | 23954790 | |
| 45 | Acetylation | ETEFYLGKRCAYVYK CCEEEECCEEEEEEE | 41.53 | 25953088 | |
| 45 | 2-Hydroxyisobutyrylation | ETEFYLGKRCAYVYK CCEEEECCEEEEEEE | 41.53 | - | |
| 52 | Methylation | KRCAYVYKAKNNTVT CEEEEEEECCCCEEC | 42.72 | 115977043 | |
| 52 | Acetylation | KRCAYVYKAKNNTVT CEEEEEEECCCCEEC | 42.72 | 25953088 | |
| 52 | Ubiquitination | KRCAYVYKAKNNTVT CEEEEEEECCCCEEC | 42.72 | - | |
| 54 | Ubiquitination | CAYVYKAKNNTVTPG EEEEEECCCCEECCC | 46.72 | 24816145 | |
| 57 | Phosphorylation | VYKAKNNTVTPGGKP EEECCCCEECCCCCC | 34.84 | 25262027 | |
| 59 | Phosphorylation | KAKNNTVTPGGKPNK ECCCCEECCCCCCCC | 17.74 | 25262027 | |
| 63 | Succinylation | NTVTPGGKPNKTRVI CEECCCCCCCCEEEE | 51.86 | - | |
| 63 | Succinylation | NTVTPGGKPNKTRVI CEECCCCCCCCEEEE | 51.86 | 27452117 | |
| 63 | Acetylation | NTVTPGGKPNKTRVI CEECCCCCCCCEEEE | 51.86 | - | |
| 63 | Ubiquitination | NTVTPGGKPNKTRVI CEECCCCCCCCEEEE | 51.86 | 27667366 | |
| 66 | 2-Hydroxyisobutyrylation | TPGGKPNKTRVIWGK CCCCCCCCEEEEEEE | 46.35 | - | |
| 66 | Ubiquitination | TPGGKPNKTRVIWGK CCCCCCCCEEEEEEE | 46.35 | 22817900 | |
| 73 | Acetylation | KTRVIWGKVTRAHGN CEEEEEEEEEECCCC | 25.99 | 25953088 | |
| 73 | Ubiquitination | KTRVIWGKVTRAHGN CEEEEEEEEEECCCC | 25.99 | 73 | |
| 83 | Sulfoxidation | RAHGNSGMVRAKFRS ECCCCCCCCCHHHHC | 1.53 | 30846556 | |
| 90 | Phosphorylation | MVRAKFRSNLPAKAI CCCHHHHCCCCHHHH | 45.94 | 29514088 | |
| 95 | 2-Hydroxyisobutyrylation | FRSNLPAKAIGHRIR HHCCCCHHHHCCEEE | 38.30 | - | |
| 95 | Ubiquitination | FRSNLPAKAIGHRIR HHCCCCHHHHCCEEE | 38.30 | 23000965 | |
| 95 | Acetylation | FRSNLPAKAIGHRIR HHCCCCHHHHCCEEE | 38.30 | 25953088 | |
| 106 | Phosphorylation | HRIRVMLYPSRI--- CEEEEEEEECCC--- | 4.89 | 25884760 | |
| 108 | Phosphorylation | IRVMLYPSRI----- EEEEEEECCC----- | 29.11 | 21406692 | |
| 109 | Methylation | RVMLYPSRI------ EEEEEECCC------ | 33.85 | 115492153 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RL35A_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RL35A_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RL35A_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| SH3G3_HUMAN | SH3GL3 | physical | 16169070 | |
| SH3G3_HUMAN | SH3GL3 | physical | 21900206 | |
| HNRL2_HUMAN | HNRNPUL2 | physical | 26344197 | |
| RNPS1_HUMAN | RNPS1 | physical | 26344197 | |
| RL10A_HUMAN | RPL10A | physical | 26344197 | |
| RL12_HUMAN | RPL12 | physical | 26344197 | |
| RL15_HUMAN | RPL15 | physical | 26344197 | |
| RL17_HUMAN | RPL17 | physical | 26344197 | |
| RL36_HUMAN | RPL36 | physical | 26344197 | |
| RL39_HUMAN | RPL39 | physical | 26344197 | |
| RL5_HUMAN | RPL5 | physical | 26344197 | |
| RS10_HUMAN | RPS10 | physical | 26344197 | |
| RS14_HUMAN | RPS14 | physical | 26344197 | |
| RS15A_HUMAN | RPS15A | physical | 26344197 | |
| RS18_HUMAN | RPS18 | physical | 26344197 | |
| RS27_HUMAN | RPS27 | physical | 26344197 | |
| RS27L_HUMAN | RPS27L | physical | 26344197 | |
| RS3A_HUMAN | RPS3A | physical | 26344197 | |
| RS5_HUMAN | RPS5 | physical | 26344197 | |
| RS6_HUMAN | RPS6 | physical | 26344197 | |
| RTF1_HUMAN | RTF1 | physical | 26344197 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 612528 | Diamond-Blackfan anemia 5 (DBA5) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-8, AND MASS SPECTROMETRY. | |